Barclays Capital analyst Emily Field conducted an extensive study of the Bayer paper.
The British investment bank Barclays left Bayer’s rating at “Equal Weight” with a price target of 30 euros after announcing a dividend cut and shortly before a capital market day. Analyst Emily Field wrote in a study published on Tuesday that she had previously viewed a dividend cut as the best way to alleviate balance sheet concerns. Now, two weeks before the investor event, there is certainty that the payout will be reduced by 95 percent. This should be well received by investors. The question now is what news there could be in March.
Stock information in focus: Bayer shares analyzed in detail on the day of the Barclays Capital recommendation
At 12:48 p.m., Bayer shares jumped in XETRA trading and increased by 0.2 percent to EUR 28.95. As a result, the paper still shows an increase potential of 3.63 percent in relation to the set price mark. 5,159,153 Bayer shares recently changed hands via XETRA. The paper has fallen by 13.9 percent since the beginning of 2024. Bayer is expected to present its upcoming financial results for Q4 2023 on March 5, 2024.
LONDON (dpa-AFX Analyzer) / editorial team finanzen.net
Publication of the original study: February 19, 2024 / 6:25 p.m. / GMT
First distribution of the original study: February 19, 2024 / 9:00 p.m. / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 Para. 1 WpHG, Art. 20 Regulation (EU) 596/2014 for the analyst firm mentioned can be found at http://web.dpa-afx.de/offenstellenpflicht/ disclosure_duty.html.
Selected leverage products on Bayer
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Bayer
The leverage must be between 2 and 20
Advertising